Literature DB >> 23261941

The first characterization of free radicals formed from cellular COX-catalyzed peroxidation.

Yan Gu1, Yi Xu, Benedict Law, Steven Y Qian.   

Abstract

Through free radical-mediated peroxidation, cyclooxygenase (COX) can metabolize dihomo-γ-linolenic acid (DGLA) and arachidonic acid (AA) to form well-known bioactive metabolites, namely, the 1-series of prostaglandins (PGs1) and the 2-series of prostaglandins (PGs2), respectively. Unlike PGs2, which are generally viewed as proinflammatory and procarcinogenic PGs, PGs1 may possess anti-inflammatory and anti-cancer activity. Previous studies using ovine COX along with spin trapping and the LC/ESR/MS technique have shown that certain exclusive free radicals are generated from different free radical reactions in DGLA and AA peroxidation. However, it has been unclear whether the differences were associated with the contrasting bioactivity of DGLA vs AA. The aim of this study was to refine the LC/MS and spin trapping technique to make it possible for the association between free radicals and cancer cell growth to be directly tested. Using a colon cancer cell line, HCA-7 colony 29, and LC/MS along with a solid-phase extraction, we were able to characterize the reduced forms of radical adducts (hydroxylamines) as the free radicals generated from cellular COX-catalyzed peroxidation. For the first time, free radicals formed in the COX-catalyzed peroxidation of AA vs DGLA and their association with cancer cell growth were assessed (cell proliferation via MTS and cell cycle distribution via propidium iodide staining) in the same experimental setting. The exclusive free radicals formed from the COX-catalyzed peroxidation of AA and DGLA were shown to be correlated with the cell growth response. Our results indicate that free radicals generated from the distinct radical reactions in COX-catalyzed peroxidation may represent the novel metabolites of AA and DGLA that correspond to their contrasting bioactivity.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23261941      PMCID: PMC4149340          DOI: 10.1016/j.freeradbiomed.2012.12.004

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  40 in total

Review 1.  Cyclooxygenases: structural, cellular, and molecular biology.

Authors:  W L Smith; D L DeWitt; R M Garavito
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

Review 2.  Mechanism of free radical oxygenation of polyunsaturated fatty acids by cyclooxygenases.

Authors:  Carol A Rouzer; Lawrence J Marnett
Journal:  Chem Rev       Date:  2003-06       Impact factor: 60.622

3.  Identification of all classes of spin-trapped carbon-centered radicals in soybean lipoxygenase-dependent lipid peroxidations of omega-6 polyunsaturated fatty acids via LC/ESR, LC/MS, and tandem MS.

Authors:  Steven Yue Qian; Gui-Hua Yue; Kenneth B Tomer; Ronald P Mason
Journal:  Free Radic Biol Med       Date:  2003-04-15       Impact factor: 7.376

Review 4.  Prostaglandins and leukotrienes: advances in eicosanoid biology.

Authors:  C D Funk
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

5.  LC/ESR/MS study of pH-dependent radical generation from 15-LOX-catalyzed DPA peroxidation.

Authors:  Preeti Purwaha; Yan Gu; Uddhav Kelavkar; Jing X Kang; Benedict Law; Erxi Wu; Steven Y Qian
Journal:  Free Radic Biol Med       Date:  2011-07-19       Impact factor: 7.376

6.  The role of cyclooxygenase in n-6 and n-3 polyunsaturated fatty acid mediated effects on cell proliferation, PGE(2) synthesis and cytotoxicity in human colorectal carcinoma cell lines.

Authors:  Yvonne E M Dommels; Merel M G Haring; Nynke G M Keestra; Gerrit M Alink; Peter J van Bladeren; Ben van Ommen
Journal:  Carcinogenesis       Date:  2003-03       Impact factor: 4.944

7.  Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy.

Authors:  Rama Pai; Brian Soreghan; Imre L Szabo; Meredith Pavelka; Dolgor Baatar; Andrzej S Tarnawski
Journal:  Nat Med       Date:  2002-03       Impact factor: 53.440

8.  Effects of polyunsaturated fatty acids on prostaglandin synthesis and cyclooxygenase-mediated DNA adduct formation by heterocyclic aromatic amines in human adenocarcinoma colon cells.

Authors:  H J J Moonen; Y E M Dommels; M van Zwam; M H M van Herwijnen; J C S Kleinjans; G M Alink; T M C M de Kok
Journal:  Mol Carcinog       Date:  2004-07       Impact factor: 4.784

9.  Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation.

Authors:  Ambra Pozzi; Xuexian Yan; Ines Macias-Perez; Shouzuo Wei; Aaron N Hata; Richard M Breyer; Jason D Morrow; Jorge H Capdevila
Journal:  J Biol Chem       Date:  2004-05-03       Impact factor: 5.157

10.  Identification of spin trapped carbon-centered radicals in soybean lipoxygenase-dependent peroxidations of omega-3 polyunsaturated fatty acids by LC/ESR, LC/MS, and tandem MS.

Authors:  Steven Yue Qian; Qiong Guo; Ronald P Mason
Journal:  Free Radic Biol Med       Date:  2003-07-01       Impact factor: 7.376

View more
  10 in total

1.  Precancerous ACF induction affects their regional distribution forsaking oxidative stress implication in 1,2-dimethylhydrazine-induced colon carcinogenesis model.

Authors:  Hichem Moulahoum; Andras-Laszlo Nagy; Bahia Djerdjouri; Simona Clichici
Journal:  Inflammopharmacology       Date:  2017-07-21       Impact factor: 4.473

2.  Knockdown of delta-5-desaturase promotes the anti-cancer activity of dihomo-γ-linolenic acid and enhances the efficacy of chemotherapy in colon cancer cells expressing COX-2.

Authors:  Yi Xu; Xiaoyu Yang; Pinjing Zhao; Zhongyu Yang; Changhui Yan; Bin Guo; Steven Y Qian
Journal:  Free Radic Biol Med       Date:  2016-04-19       Impact factor: 7.376

Review 3.  Anti-cancer activities of ω-6 polyunsaturated fatty acids.

Authors:  Yi Xu; Steven Y Qian
Journal:  Biomed J       Date:  2014 May-Jun       Impact factor: 4.910

4.  Knockdown delta-5-desaturase promotes the formation of a novel free radical byproduct from COX-catalyzed ω-6 peroxidation to induce apoptosis and sensitize pancreatic cancer cells to chemotherapy drugs.

Authors:  Xiaoyu Yang; Yi Xu; Amanda Brooks; Bin Guo; Keith W Miskimins; Steven Y Qian
Journal:  Free Radic Biol Med       Date:  2016-06-28       Impact factor: 7.376

5.  Free radical derivatives formed from cyclooxygenase-catalyzed dihomo-γ-linolenic acid peroxidation can attenuate colon cancer cell growth and enhance 5-fluorouracil's cytotoxicity.

Authors:  Yi Xu; Jin Qi; Xiaoyu Yang; Erxi Wu; Steven Y Qian
Journal:  Redox Biol       Date:  2014-03-20       Impact factor: 11.799

6.  Specific delivery of delta-5-desaturase siRNA via RNA nanoparticles supplemented with dihomo-γ-linolenic acid for colon cancer suppression.

Authors:  Yi Xu; Lizhi Pang; Hongzhi Wang; Congcong Xu; Harshit Shah; Peixuan Guo; Dan Shu; Steven Y Qian
Journal:  Redox Biol       Date:  2018-12-18       Impact factor: 11.799

Review 7.  An advanced Electron Spin Resonance (ESR) spin-trapping and LC/(ESR)/MS technique for the study of lipid peroxidation.

Authors:  Yi Xu; Yan Gu; Steven Y Qian
Journal:  Int J Mol Sci       Date:  2012-11-12       Impact factor: 5.923

Review 8.  Oxidative stress in the pathogenesis of colorectal cancer: cause or consequence?

Authors:  Martina Perše
Journal:  Biomed Res Int       Date:  2013-05-14       Impact factor: 3.411

9.  Knockdown delta-5-desaturase in breast cancer cells that overexpress COX-2 results in inhibition of growth, migration and invasion via a dihomo-γ-linolenic acid peroxidation dependent mechanism.

Authors:  Yi Xu; Xiaoyu Yang; Tao Wang; Liu Yang; Yu-Ying He; Keith Miskimins; Steven Y Qian
Journal:  BMC Cancer       Date:  2018-03-27       Impact factor: 4.430

10.  Dihomo-γ-linolenic acid inhibits growth of xenograft tumors in mice bearing human pancreatic cancer cells (BxPC-3) transfected with delta-5-desaturase shRNA.

Authors:  Xiaoyu Yang; Yi Xu; Di Gao; Liu Yang; Steven Y Qian
Journal:  Redox Biol       Date:  2018-10-15       Impact factor: 11.799

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.